Trial intelligence / Profile preview

Synbiotic Addition to Standard Triple Therapy for H. Pylori Eradication in Children

NCT03165253Completed

Sponsor
Zonguldak Bülent Ecevit University
Start
Jun 2011
Primary completion
Jun 2012
Modality
Yeast Strains, Defined Consortia, Bacterial Strains
01

Overview

Randomised trial of bifidobacterium animalis lactis in Helicobacter pylori infection (2 arms), sponsored by Zonguldak Bülent Ecevit University. Primary endpoint: Eradication rates. Started Jun 2011; status: completed.

02

Drugs

bifidobacterium animalis lactis
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT03165253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03165253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call